Center for Drug Evaluation and Research growing crisis around HIV testing and treatment and an inter-agency dispute between officials from the former Bureau of Drugs and officials from the former Bureau of Biologics over whether to approve Genentech's Activase (tissue plasminogen activator) led to the split. In its original form, CDER was composed of six offices: Management, Compliance, Drug Standards, Drug Evaluation I, Drug Evaluation II, Epidemiology and Biostatistics, and Research Resources. The Division of Antiviral Products was added in 1989 under Drug Evaluation II due to the large amount of drugs proposed for treating AIDS. The Office of Generic Drugs was also formed. In 2002,
Ellex Medical Lasers sells solid-state photodisruptors, photocoagulators and SLT devices for treating cataract, glaucoma and retinal conditions. As of 2007, the only Innovative Imaging Inc product is the Eye Cubed diagnostic ultrasound system. Ellex holds a number of core patents which it claims act to differentiate the laser portfolio. These include: Ellex Medical Lasers Ellex Medical Lasers is an Australia-based company that is engaged in the business of designing, manufacturing and marketing a line of lasers used by ophthalmologists. Ellex manufactures and sells photodisruptors, photocoagulators and selective laser trabeculoplasty (SLT) system for treating cataract, retina and glaucoma conditions. Ellex was first established as